Use the search parameters below to filter talks:

2015 - IPITA-IXA-CTS (Melbourne)

Islet Xenotransplantation
16 November 2015  /  11:00 - 12:30
PERV (Porcine Endogenous Retrovirus) integration and expression in pancreatic islets and other tissues in neonatal and adult pigs
Presenter: Nizar Mourad, Belgium
Plasma microRNA-375 – A single test to quantitate injury to porcine islet grafts and to diagnose accelerated porcine islet graft loss in nonhuman primates?
Presenter: Raza Naqvi, United States
A New Bioinformatics Analysis Reveals Intestinal Infection as a Possible Cause of Intrahepatic Graft Rejection in Non-human Primate Porcine Islet Xenotransplantation
Presenter: Hyun Je Kim, Korea
Anti-CD2 producing pig xenografts effect localized depletion of human T cells in a humanized mouse model
Presenter: Jamie Brady, Australia
Improving porcine islet yield with new recombinant class I (rC1) and class II (rC2) collagenases in combination with BP Protease, an animal-free enzyme mixture.
Presenter: Balamurugan Appakalai, United States
Transplantation of alginate-based microencapsulated neonatal porcine islets in diabetes.
Presenter: Azadeh Hosseini-Tabatabaei, Canada

Pancreas and Islet Transplantation: Imaging, Biopsies, and Biomarkers
18 November 2015  /  11:00 - 12:30
Efficacy of contrast-enhanced ultrasonography for the prediction of the endocrine function of the graft in clinical pancreas transplantation.
Presenter: Naohiro Aida, Japan
Higher baseline levels of the bone hormone undercarboxylated osteocalcin independently predict improved islet cell transplantation outcomes
Presenter: Kirstie Danielson, United States
Biopsies in pancreas transplantation: The laparoscopic approach
Presenter: Pablo Uva, Argentina
Post-transplantation CA19-9 levels correlate with islet purity and long-term metabolic results after islet transplantation in type 1 diabetes
Presenter: Marie-Christine Vantyghem, France
Continuous oxygen delivery improves oxygenation of tissue-engineered islet grafts in vivo as measured with fluorine-19 magnetic resonance spectroscopy
Presenter: Bradley Weegman, United States
Vesicular nucleotide transporter (vnut) protein expressed during the in vitro differentiation of human induced pluripotent stem cells to insulin producing beta cells: A possible marker for beta cell maturation
Presenter: Kenneth Brayman, United States

Hepatocyte Transplantation
18 November 2015  /  11:00 - 12:30
20 Years of Experience in Isolation and Evaluation of Human Hepatocytes for Cell-Based Therapy
Presenter: Roberto Gramignoli, Sweden
Prolonged survival of hepatocytes transplanted for glycogen storage disease type 1b
Presenter: Kyo Won Lee, Korea
Neonatal DCD livers with long warm ischemic times can produce good quality clinical grade hepatocytes.
Presenter: Sharon Lehec, United Kingdom
Suppression of the innate immune response using cytoptopic therapeutic agents to prevent early cell loss following hepatocyte transplantation
Presenter: Charlotte Lee, United Kingdom
Hepatocyte transplantation normalizes hypercholesterolemia and aortic accumulation of cholesterol in apolipoprotein E knockout mice
Presenter: Carl Jorns, Sweden
Two cases of hepatocyte transplantation for urea cycle disorders by using hepatocytes isolated from living donor reduced grafts
Presenter: Takanobu Shigeta, Japan
The influence of the synergistic effect of neutral protease derived from Clostridium histolyticum and clostripain on the hepatocyte isolation
Presenter: Satoru Yoshida, Japan

Cellular Encapsulation
17 November 2015  /  11:00 - 12:30
Endotoxin, protein, and microbiological impurities in alginate hydrogels correlate with immune-mediated destruction after islet transplantation
Presenter: Rahul Krishnan, United States

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada

Info

Privacy Policy
Terms of Use
Copyright Notice